What Is Dutasteride?
If you have been researching hair loss treatment in Japan, you have probably come across dutasteride and wondered exactly when you can expect to see a difference. This is a common and reasonable question, especially for expats who are new to the Japanese healthcare system and want a realistic sense of the timeline before committing to daily medication.
This article walks through what dutasteride is, how it works, and what a realistic month-by-month timeline looks like based on published clinical data, including a long-term study conducted in Japanese men.
- What dutasteride is and how it differs from other oral hair loss treatments
- How the medication works at a biological level
- A realistic, evidence-based timeline of when changes typically become noticeable
- What influences cost and what to expect during treatment in Tokyo
- Who is, and is not, generally a suitable candidate
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
Dutasteride is an oral medication originally developed for benign prostatic hyperplasia (BPH) and later studied specifically for male pattern hair loss, also known as androgenetic alopecia (AGA). In Japan, dutasteride for AGA is available under the brand name Zagallo (ザガーロ), which received manufacturing and marketing approval from Japan’s Ministry of Health, Labour and Welfare in 2015 and was subsequently launched by GlaxoSmithKline. Generic dutasteride capsules for the same indication have since been approved as well.
It is important to note that dutasteride prescribed for AGA in Japan is a separate approved product from dutasteride prescribed for BPH, even though the active ingredient is identical. AGA treatment with dutasteride is not covered by Japan’s national health insurance and is provided on a self-pay basis, as it is considered a cosmetic/lifestyle treatment rather than a medically necessary one.
How Dutasteride Works for Hair Loss
Androgenetic alopecia is driven largely by dihydrotestosterone (DHT), a hormone derivative that gradually shrinks (miniaturises) genetically susceptible hair follicles. DHT is produced when the enzyme 5-alpha reductase converts testosterone into DHT.
There are two main forms of this enzyme, Type I and Type II. Dutasteride inhibits both, whereas some other oral options only inhibit Type II. Clinical reports indicate that this broader inhibition allows dutasteride to reduce circulating DHT levels more substantially than Type II-selective inhibitors, although greater DHT suppression does not automatically translate into proportionally greater visible hair regrowth for every individual.
Why Results Are Not Immediate
Hair growth happens in cycles, and a follicle that has been miniaturised by DHT needs sustained time in a lower-DHT environment before it can produce a thicker, longer-lasting hair. This biological cycle is the main reason dutasteride requires months, not days or weeks, before changes become visible.
Realistic Results Timeline: What to Expect Month by Month
Expectations matter a great deal with this medication. Clinical trial data, rather than marketing claims, gives the most realistic picture of what typically happens and when.
Months 0–3: Stabilisation Phase
During the first few months, the main goal is to slow further shedding rather than to see new growth. Some patients notice a temporary increase in shedding in the first several weeks, which reflects the hair cycle resetting rather than the treatment failing.
Months 3–6: Early Measurable Change
A placebo-controlled phase III trial of dutasteride 0.5 mg once daily in 153 men with male pattern hair loss found a mean increase in hair count of 12.2 hairs/cm² in the dutasteride group after six months, compared with 4.7 hairs/cm² in the placebo group, a statistically significant difference. This is the point at which many patients first notice a subjective difference, though it is often subtle rather than dramatic.
Months 6–12: Continued Improvement
A long-term, open-label study following 110 Japanese men with androgenetic alopecia through 52 weeks of daily dutasteride 0.5 mg treatment reported continued improvement in hair count, hair width, and investigator-assessed global appearance from baseline through week 52. This suggests that, for many patients, gains continue to build well beyond the six-month mark rather than plateauing early.
Beyond 12 Months
Longer-term data, including studies extending to five years, generally describe sustained improvement or maintenance of results with continued treatment, though individual responses vary considerably and stopping treatment is associated with gradual loss of the gained benefit over time.
Cost of Dutasteride Treatment in Tokyo
Because dutasteride for AGA is not covered by insurance in Japan, cost is entirely self-pay and varies by clinic, dosage, and whether a branded or generic product is prescribed. Pricing also depends on whether the medication is combined with other treatments as part of a broader hair loss plan. Please see the clinic’s official price page or contact us for a current quote. For an accurate quote, please book a consultation.
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
Who Is a Good Candidate for Dutasteride?
Dutasteride is generally considered for adult men with early to moderate androgenetic alopecia who are looking for an oral, once-daily option and who understand that visible results take patience. At BIOTOPE CLINIC in Shirokanedai, we frequently see patients who have already tried topical products without a clear routine or realistic timeline, and who are looking for a structured, physician-guided approach instead.
Dutasteride is not appropriate for women, particularly those who are pregnant or may become pregnant, due to the risk of effects on a male fetus.
Men with significant liver disease, a history of certain hormone-sensitive conditions, or those planning to conceive in the near term should discuss these factors carefully with a physician before starting treatment, since sexual side effects such as decreased libido and erectile dysfunction have been reported in a minority of users. Some men with a hereditary predisposition to hair loss also choose to explore genetic testing, available at BIOTOPE CLINIC, to better understand their individual risk profile before deciding on a treatment plan.
Where to Get Dutasteride Treatment in Tokyo
Within our clinic group, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology & Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Jun Karibe’s team. Dutasteride and other AGA treatment is handled at BIOTOPE CLINIC, which is also the group’s men’s health branch. Bookings and enquiries in English: LINE or WhatsApp.
Common Misconceptions About Dutasteride Timelines
One frequent misunderstanding is that dutasteride works faster than other oral hair loss treatments simply because it inhibits both forms of the 5-alpha reductase enzyme. Broader enzyme inhibition does not shorten the biological hair cycle, so the realistic timeline of several months to see initial change, and closer to a year for more meaningful improvement, generally still applies.
Another common misconception is that early shedding in the first few weeks means the medication “isn’t working” or has caused hair loss. This initial phase is a recognised part of how hair follicles respond as the cycle resets, and clinical trial data cited above shows measurable improvement over dutasteride is typically assessed from the three-to-six-month mark onward, not the first few weeks.
A third point of confusion for expats is assuming that dutasteride approved for prostate conditions abroad automatically applies to hair loss treatment in Japan. In Japan, the AGA indication is a separately approved product (Zagallo) from the BPH-indicated dutasteride product, and only the AGA-approved product and its generics should be prescribed for hair loss.
Frequently Asked Questions
- Q. How soon will I notice less shedding on dutasteride?
- Most published data suggests measurable change in hair count becomes apparent from around three to six months of consistent daily use, though this varies by individual. Noticing less hair in the shower or on your pillow before that point is not necessarily a sign of treatment failure.
- Q. Is dutasteride more effective than other oral AGA treatments?
- Dutasteride inhibits both Type I and Type II of the 5-alpha reductase enzyme, while some alternatives only inhibit Type II, and clinical reports indicate this can lead to greater DHT suppression. However, individual response varies, and a physician consultation is the best way to determine which option suits your particular case.
- Q. What happens if I stop taking dutasteride?
- Available long-term data indicates that benefits gained during treatment tend to diminish gradually after stopping, as DHT levels return toward baseline. This is a key consideration for anyone weighing dutasteride as a long-term commitment rather than a short course.
- Q. Can women use dutasteride for hair loss?
- Dutasteride is not recommended for women, particularly those who are or may become pregnant, due to potential risks to a male fetus. Women interested in hair loss treatment should discuss alternative, appropriate options with a physician.
Have a question about this treatment?
Message us on LINE or WhatsApp — our English-speaking team usually replies the same day.
Summary
Dutasteride is not a quick fix: published clinical data, including a 52-week study in Japanese men, points to a realistic timeline of several months for early measurable change and closer to a year or more for fuller results, with continued treatment needed to maintain benefits. Understanding this timeline in advance is the best way to set realistic expectations and stay consistent with treatment. If you have questions about dutasteride, both BIOTOPE CLINIC (Shirokanedai, Minato-ku) and Kojimachi Dermatology & Plastic Surgery Clinic (Ichigaya, Chiyoda-ku) offer English-language consultation with Dr. Karibe and his team. Dutasteride treatment is primarily handled at BIOTOPE CLINIC. English enquiries: LINE or WhatsApp.
24/7 Consultation & Booking
Book a Consultation or Treatment
Our English-speaking team responds via LINE or WhatsApp — usually the same day.
References
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. Journal of the American Academy of Dermatology. 2010;63(2):252-258.
- Tsunemi Y, Irisawa R, Yoshiie H, et al. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. The Journal of Dermatology. 2016;43(9):1051-1058.
- Lee Y, et al. Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. Annals of Dermatology. 2025.
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan.
Related Articles
You may also find these articles useful.
- How to Get Dutasteride Legally in Japan: Guide for Expats
- Dutasteride in Japan: Approval, Prescription & English Care
- AGA vs Finasteride & Minoxidil: Tokyo Regenerative Care
- Hair Mesotherapy Tokyo: Manual vs Hydro-Injector AGA
- English-Speaking Dermatologist Tokyo: Hair Loss & AGA
SUPERVISED BY
Dr. Jun Karibe
MD
Director
Education & Career
Certifications
Awards
MEDICAL REVIEW
